Tristetraprolin Posttranscriptionally Downregulates TRAIL Death Receptors

Won Hyeok Lee1,2, Myung Woul Han1,2, Song Hee Kim1,2

  • 1Department of Otorhinolaryngology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 44033, Korea.

Cells
|August 14, 2020
PubMed

Insights

Tristetraprolin (TTP) regulates cancer cell sensitivity to Tumor Necrosis Factor (TNF)-related apoptosis-inducing ligand (TRAIL) therapy. TTP controls the stability of TRAIL death receptor (DR) mRNA, impacting treatment response.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Immunology

Background:

  • Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) shows promise for cancer therapy but faces resistance in many primary cancers.
  • The mechanisms underlying TRAIL resistance, particularly concerning death receptor (DR) mRNA stability, remain incompletely understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms controlling TRAIL death receptor (DR) mRNA stability.
  • To investigate the role of tristetraprolin (TTP) in regulating TRAIL sensitivity in cancer cells.

Main Methods:

  • Analysis of AU-rich elements (AREs) in the 3'-untranslated regions (3'-UTRs) of DR4 and DR5 mRNA.
  • Assessment of TTP binding to AREs and its effect on DR4/5 mRNA decay.
  • Evaluation of TTP's impact on TRAIL sensitivity in colon cancer cells through overexpression and down-regulation studies.

Main Results:

  • Tristetraprolin (TTP), an ARE-binding protein, binds to multiple AREs in the 3'-UTRs of DR4 and DR5 mRNA, enhancing their decay.
  • TTP overexpression confers TRAIL resistance in colon cancer cells by reducing DR4/5 expression.
  • Down-regulation of TTP increases TRAIL sensitivity by upregulating DR4/5 expression.

Conclusions:

  • TTP plays a critical role in posttranscriptional regulation of TRAIL death receptors, influencing TRAIL sensitivity in cancer.
  • TTP status may serve as a predictive biomarker for TRAIL-based cancer treatments.

Related Concept Videos

GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.6K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.7K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
84.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.9K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.6K